Selected research
Industry Research
Plasma for Fractionation Industry Research Report 2026
Market perspective
The global Plasma for Fractionation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Plasma for Fractionation market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Plasma for Fractionation market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Plasma for Fractionation market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Plasma for Fractionation include Biotest, BPL, CBPO, CSL, Grifols, Kedrion, LFB Group, Octapharma and Hualan Bio, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Plasma for Fractionation market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Plasma for Fractionation.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plasma for Fractionation Market by Company
Biotest
BPL
CBPO
CSL
Grifols
Kedrion
LFB Group
Octapharma
Hualan Bio
RAAS
Takeda
Plasma for Fractionation Segment by Type
Recovered Plasma
Source Plasma
Plasma for Fractionation Segment by Application
Albumin
Immune Globulin
Coagulation Factor
Others
Plasma for Fractionation Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma for Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma for Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma for Fractionation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Plasma for Fractionation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Recovered Plasma
- Source Plasma
Applications
- Albumin
- Immune Globulin
- Coagulation Factor
- Others
Companies covered
- Biotest
- BPL
- CBPO
- CSL
- Grifols
- Kedrion
- LFB Group
- Octapharma
- Hualan Bio
- RAAS
- Takeda
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Plasma for Fractionation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Recovered Plasma
- 2.2.3 Source Plasma
- 2.3 Plasma for Fractionation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Albumin
- 2.3.3 Immune Globulin
- 2.3.4 Coagulation Factor
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Plasma for Fractionation Breakdown Data by Type
- 3.1 Global Plasma for Fractionation Historic Market Size by Type (2021-2026)
- 3.2 Global Plasma for Fractionation Forecasted Market Size by Type (2027-2032)
4 Plasma for Fractionation Breakdown Data by Application
- 4.1 Global Plasma for Fractionation Historic Market Size by Application (2021-2026)
- 4.2 Global Plasma for Fractionation Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Plasma for Fractionation Market Perspective (2021-2032)
- 5.2 Global Plasma for Fractionation Growth Trends by Region
- 5.2.1 Global Plasma for Fractionation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Plasma for Fractionation Historic Market Size by Region (2021-2026)
- 5.2.3 Plasma for Fractionation Forecasted Market Size by Region (2027-2032)
- 5.3 Plasma for Fractionation Market Dynamics
- 5.3.1 Plasma for Fractionation Industry Trends
- 5.3.2 Plasma for Fractionation Market Drivers
- 5.3.3 Plasma for Fractionation Market Challenges
- 5.3.4 Plasma for Fractionation Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Plasma for Fractionation Players by Revenue
- 6.1.1 Global Top Plasma for Fractionation Players by Revenue (2021-2026)
- 6.1.2 Global Plasma for Fractionation Revenue Market Share by Players (2021-2026)
- 6.2 Global Plasma for Fractionation Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Plasma for Fractionation Head Office and Area Served
- 6.4 Global Plasma for Fractionation Players, Product Type & Application
- 6.5 Global Plasma for Fractionation Manufacturers Established Date
- 6.6 Global Plasma for Fractionation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Plasma for Fractionation Market Size (2021-2032)
- 7.2 North America Plasma for Fractionation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Plasma for Fractionation Market Size by Country (2021-2026)
- 7.4 North America Plasma for Fractionation Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Plasma for Fractionation Market Size (2021-2032)
- 8.2 Europe Plasma for Fractionation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Plasma for Fractionation Market Size by Country (2021-2026)
- 8.4 Europe Plasma for Fractionation Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Plasma for Fractionation Market Size (2021-2032)
- 9.2 Asia-Pacific Plasma for Fractionation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Plasma for Fractionation Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Plasma for Fractionation Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Plasma for Fractionation Market Size (2021-2032)
- 10.2 South America Plasma for Fractionation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Plasma for Fractionation Market Size by Country (2021-2026)
- 10.4 South America Plasma for Fractionation Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Plasma for Fractionation Market Size (2021-2032)
- 11.2 Middle East & Africa Plasma for Fractionation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Plasma for Fractionation Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Plasma for Fractionation Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Biotest
- 12.1.1 Biotest Company Information
- 12.1.2 Biotest Business Overview
- 12.1.3 Biotest Revenue in Plasma for Fractionation Business (2021-2026)
- 12.1.4 Biotest Plasma for Fractionation Product Portfolio
- 12.1.5 Biotest Recent Developments
- 12.2 BPL
- 12.2.1 BPL Company Information
- 12.2.2 BPL Business Overview
- 12.2.3 BPL Revenue in Plasma for Fractionation Business (2021-2026)
- 12.2.4 BPL Plasma for Fractionation Product Portfolio
- 12.2.5 BPL Recent Developments
- 12.3 CBPO
- 12.3.1 CBPO Company Information
- 12.3.2 CBPO Business Overview
- 12.3.3 CBPO Revenue in Plasma for Fractionation Business (2021-2026)
- 12.3.4 CBPO Plasma for Fractionation Product Portfolio
- 12.3.5 CBPO Recent Developments
- 12.4 CSL
- 12.4.1 CSL Company Information
- 12.4.2 CSL Business Overview
- 12.4.3 CSL Revenue in Plasma for Fractionation Business (2021-2026)
- 12.4.4 CSL Plasma for Fractionation Product Portfolio
- 12.4.5 CSL Recent Developments
- 12.5 Grifols
- 12.5.1 Grifols Company Information
- 12.5.2 Grifols Business Overview
- 12.5.3 Grifols Revenue in Plasma for Fractionation Business (2021-2026)
- 12.5.4 Grifols Plasma for Fractionation Product Portfolio
- 12.5.5 Grifols Recent Developments
- 12.6 Kedrion
- 12.6.1 Kedrion Company Information
- 12.6.2 Kedrion Business Overview
- 12.6.3 Kedrion Revenue in Plasma for Fractionation Business (2021-2026)
- 12.6.4 Kedrion Plasma for Fractionation Product Portfolio
- 12.6.5 Kedrion Recent Developments
- 12.7 LFB Group
- 12.7.1 LFB Group Company Information
- 12.7.2 LFB Group Business Overview
- 12.7.3 LFB Group Revenue in Plasma for Fractionation Business (2021-2026)
- 12.7.4 LFB Group Plasma for Fractionation Product Portfolio
- 12.7.5 LFB Group Recent Developments
- 12.8 Octapharma
- 12.8.1 Octapharma Company Information
- 12.8.2 Octapharma Business Overview
- 12.8.3 Octapharma Revenue in Plasma for Fractionation Business (2021-2026)
- 12.8.4 Octapharma Plasma for Fractionation Product Portfolio
- 12.8.5 Octapharma Recent Developments
- 12.9 Hualan Bio
- 12.9.1 Hualan Bio Company Information
- 12.9.2 Hualan Bio Business Overview
- 12.9.3 Hualan Bio Revenue in Plasma for Fractionation Business (2021-2026)
- 12.9.4 Hualan Bio Plasma for Fractionation Product Portfolio
- 12.9.5 Hualan Bio Recent Developments
- 12.10 RAAS
- 12.10.1 RAAS Company Information
- 12.10.2 RAAS Business Overview
- 12.10.3 RAAS Revenue in Plasma for Fractionation Business (2021-2026)
- 12.10.4 RAAS Plasma for Fractionation Product Portfolio
- 12.10.5 RAAS Recent Developments
- 12.11 Takeda
- 12.11.1 Takeda Company Information
- 12.11.2 Takeda Business Overview
- 12.11.3 Takeda Revenue in Plasma for Fractionation Business (2021-2026)
- 12.11.4 Takeda Plasma for Fractionation Product Portfolio
- 12.11.5 Takeda Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst